Pretargeted Radioimmunotherapy in Metastatic Colorectal Cancer

Summary

Phase I/II, Open-labeled, Prospective, Multi-center study of a Pretargeted Radioimmunotherapy in metastatic colorectal cancer with ractionated injections of TF2 plus 90Y-IMP288 (RITCOLON).

Timeline

Start

2015-01-27

Primary completion

2017-09-20

Completion

2017-12-20

Outcome

Outcome not reported

Stopped (Enrollment): “Premature termination of recruitment due to the discontinuation of product supply by the project's industrial partner.”

Drugs

Indications